LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio response to NOU 2023 – 18 Gene technology in a sustainable future

    22/02/2024

    POLICY DOCUMENT

    Brussels, 22 February 2024

    EuropaBio welcomes the opportunity to comment on the Committee report Gene technology in a sustainable future. Our comments focus on the general principle of the majority’s proposal and on organisms intended for food, feed and agriculture, as well as other releases for industrial and environmental purposes (excluding GMO medicinal products).

    EuropaBio considers that the Committee’s general assessment of the current situation is accurate: gene technology can contribute significantly to a more sustainable future; today’s regulations and their implementation create many obstacles to realise its full potential; current gene technology regulations, management and policies inhibit innovation and access to safe and useful products.

    We fully agree with the recommendation of the Committee to modernise the current regulation of organisms and products developed using gene technology and advocate for similar modernisation of the EU GM framework. Furthermore, we also support the Committee’s view that any new proposal for regulating products developed with gene technology should consider all living organisms, i.e. plants, animals, and microorganisms. The scope of the proposal should be clear with regard to fermentation products: products produced using genetically modified microorganisms (GMMs) should not fall in scope of the Gene Technology Act.

    See our comments in the document

    EuropaBio response to NOU 2023 - 18 Gene technology in a sustainable future


    Download

    Share
    Communications Team
    Communications Team

    Related posts

    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more

    Important links

    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies
    • Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.